MedGenesis Therapeutix Inc.

MedGenesis Therapeutix (MedGenesis) is a privately-held biopharmaceutical company committed to developing and commercializing innovative therapeutics to provide life-enhancing treatments to patients with serious neurologic diseases. MedGenesis is a worldwide leader in Convection Enhanced Delivery (CED), a minimally invasive technique that provides for targeted, local treatment of CNS conditions such as Parkinsonís disease, Epilepsy, Brain Cancer and other severely debilitating diseases of the CNS.

© MedGenesis Therapeutix Inc.


What's New

11-Feb-2018: MedGenesis Therapeutix Announces Termination of GDNF Option Agreement with Pfizer Inc.

1-Sep-2017: MedGenesis Therapeutix Announces Successful National Scientific Advice Meetings for GDNF in Parkinson's Disease